TY  - GEN 
AU  - Caba Pérez, Octavio
AU  - Irigoyen, Antonio
AU  - Jiménez Luna, Cristina
AU  - Benavides, Manuel
AU  - Ortuño, Francisco M.
AU  - Gallego, Javier
AU  - Rojas Ruiz, Ignacio
AU  - Guillen-Ponce, Carmen
AU  - Torres Perales, Carolina
AU  - Aranda, Enrique
AU  - Prados Salazar, José Carlos
PY  - 2016
UR  - https://hdl.handle.net/10481/101016
AB  - Erlotinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that showed activity against pancreatic ductal adenocarcinoma (PDAC). The drug's most frequently reportedside effectasa result ofEGFR inhibition is skin rash (SR), a...
LA  - eng
PB  - Elsevier
KW  - Pancreatic ductal adenocarcinoma
KW  - Erlotinib
KW  - Skin
KW  - Microarray
TI  - Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients
DO  - 10.1016/j.taap.2016.10.003
ER  -